These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10599730

  • 1. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome.
    Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C, Ulloa-Aguirre A, Escobar ME, Barontini M, Veldhuis JD.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4629-36. PubMed ID: 10599730
    [Abstract] [Full Text] [Related]

  • 2. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome.
    García-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M.
    Eur J Endocrinol; 1998 Dec; 139(6):621-30. PubMed ID: 9916868
    [Abstract] [Full Text] [Related]

  • 3. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [Abstract] [Full Text] [Related]

  • 4. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
    Garcia-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M.
    Eur J Endocrinol; 2002 Aug; 147(2):207-16. PubMed ID: 12153742
    [Abstract] [Full Text] [Related]

  • 5. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A, Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [Abstract] [Full Text] [Related]

  • 6. Disruption of the joint synchrony of luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome.
    Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M.
    J Clin Endocrinol Metab; 2001 Jan; 86(1):72-9. PubMed ID: 11231981
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
    Barontini M, García-Rudaz MC, Veldhuis JD.
    Arch Med Res; 2001 Jan; 32(6):544-52. PubMed ID: 11750729
    [Abstract] [Full Text] [Related]

  • 8. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [Abstract] [Full Text] [Related]

  • 9. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M, Aloi JA, Iranmanesh A, Mulligan TM, Veldhuis JD.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [Abstract] [Full Text] [Related]

  • 10. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C, Olivares A, Söderlund D, López-Alvarenga JC, Zambrano E, Veldhuis JD, Ulloa-Aguirre A, Méndez JP.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents.
    Ropelato MG, Rudaz MC, Escobar ME, Bengolea SV, Calcagno ML, Veldhuis JD, Barontini M.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3602-10. PubMed ID: 19567528
    [Abstract] [Full Text] [Related]

  • 13. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 14. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 15. Differential responses of biologically active luteinizing hormone secretion in older versus young men to interruption of androgen negative feedback.
    Veldhuis JD, Urban RJ, Dufau ML.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1763-70. PubMed ID: 7989483
    [Abstract] [Full Text] [Related]

  • 16. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [Abstract] [Full Text] [Related]

  • 17. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men.
    Aloi JA, Bergendahl M, Iranmanesh A, Veldhuis JD.
    J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547
    [Abstract] [Full Text] [Related]

  • 18. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D, Bützow T, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
    [Abstract] [Full Text] [Related]

  • 20. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS.
    Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frölich M, Meinders AE, Krans HM, Pijl H.
    Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E865-72. PubMed ID: 11882506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.